CSF-1-activated macrophages are target-directed and essential mediators of schwann cell dedifferentiation and dysfunction in Cx32-deficient mice

Nonuniform molecular features of myelinating Schwann cells in models for CMT1: Distinct disease patterns are associated with NCAM and c-Jun upregulation

(2014) Dennis Klein et al.   GLIA

Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A

(2014) Robert Fledrich et al.   NATURE MEDICINE

Neuregulin-1 alleviates Charcot-Marie-Tooth disease in rats

(2014) Rudolf Martini   NATURE MEDICINE

Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment

(2014) Theerawut Chanmee et al.   Cancers

Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration

(2013) Rudolf Martini et al.   AMERICAN JOURNAL OF PATHOLOGY

Animal models and therapeutic prospects for Charcot-Marie-Tooth disease

(2013) Delphine Bouhy et al.   ANNALS OF NEUROLOGY

Macrophages and CSF-1

(2013) Christina V Jones et al.   Organogenesis

Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease

(2012) R. Fledrich et al.   BRITISH MEDICAL BULLETIN

Acute injury in the peripheral nervous system triggers an alternative macrophage response

(2012) Elke Ydens et al.   Journal of Neuroinflammation

p38 MAPK Activation Promotes Denervated Schwann Cell Phenotype and Functions as a Negative Regulator of Schwann Cell Differentiation and Myelination

(2012) D. P. Yang et al.   JOURNAL OF NEUROSCIENCE

Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’

(2012) Ravid Shechter et al.   JOURNAL OF PATHOLOGY

A Central Role for the ERK-Signaling Pathway in Controlling Schwann Cell Plasticity and Peripheral Nerve Regeneration In Vivo

(2012) Ilaria Napoli et al.   NEURON

Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot–Marie–Tooth disease type 1X

(2011) Janos Groh et al.   BRAIN

The brain tumor microenvironment

(2011) Nikki A. Charles et al.   GLIA

c-Jun expression in human neuropathies: a pilot study

(2011) Elspeth J. Hutton et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

MCP-1/CCL2 Modifies Axon Properties in a PMP22-Overexpressing Mouse Model for Charcot-Marie-Tooth 1A Neuropathy

(2010) Bianca Kohl et al.   AMERICAN JOURNAL OF PATHOLOGY

Macrophage Diversity Enhances Tumor Progression and Metastasis

(2010) Bin-Zhi Qian et al.   CELL

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

(2010) Alberto Mantovani et al.   CURRENT OPINION IN IMMUNOLOGY

Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot–Marie–Tooth 1X

(2010) Janos Groh et al.   HUMAN MOLECULAR GENETICS

Alternative Activation of Macrophages: Mechanism and Functions

(2010) Siamon Gordon et al.   IMMUNITY

Schwann Cell Dedifferentiation Is Independent of Mitogenic Signaling and Uncoupled to Proliferation

(2010) Paula V. Monje et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway

(2008) Stefan Fischer et al.   GLIA